Together, these findings suggest that lung tissue RNF128 prevents LPS-induced lung injury, immune cell infiltration and inflammation, making it a potential therapeutic target in treating ALI (Fig. 8H). The gene discussed is RNF128; the disease is acute respiratory distress syndrome.